Literature DB >> 4102701

Detection and characterization of immune complexes by the platelet aggregation test. II. Circulating complexes.

G Myllylä, A Vaheri, K Penttinen.   

Abstract

Mesh:

Substances:

Year:  1971        PMID: 4102701      PMCID: PMC1712928     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  4 in total

1.  Immunopathology.

Authors:  R R Coombs
Journal:  Br Med J       Date:  1968-03-09

Review 2.  Immune-complex disease.

Authors:  C L Christian
Journal:  N Engl J Med       Date:  1969-04-17       Impact factor: 91.245

3.  Soluble antigen-antibody complexes and platelet aggregation.

Authors:  K Penttinen; G Myllylä; O Mäkelä; A Vaheri
Journal:  Acta Pathol Microbiol Scand       Date:  1969

4.  Detection and characterization of immune complexes by the platelet aggregation test. I. Complexes formed in vitro.

Authors:  K Penttinen; A Vaheri; G Myllylä
Journal:  Clin Exp Immunol       Date:  1971-03       Impact factor: 4.330

  4 in total
  12 in total

1.  Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy.

Authors:  A Engström-Laurent; R Hällgren
Journal:  Ann Rheum Dis       Date:  1985-02       Impact factor: 19.103

2.  Platelet aggregation and cryo-IgM in the study of hepatitis and immune complex states.

Authors:  K Penttinen; O Wager; J A Räsänen; G Myllylä; E Haapanen
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

3.  Evidence for circulating immune complexes in sarcoidosis.

Authors:  E Hedfors; R Norberg
Journal:  Clin Exp Immunol       Date:  1974-03       Impact factor: 4.330

4.  Immune reactions of platelets and their clinical significance.

Authors:  C Mueller-Eckhardt
Journal:  Klin Wochenschr       Date:  1975-10-01

5.  Platelet associated immunoglobulins and complement in idiopathic thrombocytopenic purpura.

Authors:  J Winiarski; G Holm
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

6.  Inhibition of IgG complex-induced platelet aggregation by antiglobulin-active cryoglobulin IgM components.

Authors:  O Wager; K Penttinen; J A Räsänen; G Myllylä
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

7.  Platelet aggregation by hepatitis B surface antigen-antibody complexes.

Authors:  H Daugharty; R Gogel
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

8.  Serum amino terminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis: relation to clinical and serological parameters of inflammation during 8 and 24 months' treatment with levamisole, penicillamine, or azathioprine.

Authors:  K Hørslev-Petersen; K D Bentsen; A Engström-Laurent; P Junker; P Halberg; I Lorenzen
Journal:  Ann Rheum Dis       Date:  1988-02       Impact factor: 19.103

9.  Eosinophil involvement in rheumatoid arthritis as reflected by elevated serum levels of eosinophil cationic protein.

Authors:  R Hällgren; N Feltelius; K Svenson; P Venge
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

10.  Gold nephropathy: serologic data suggesting an immune complex disease.

Authors:  T Palosuo; T T Provost; F Milgrom
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.